173 related articles for article (PubMed ID: 9154658)
21. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy.
Balducci R; Toscano V; Pasquino AM; Mangiantini A; Municchi G; Armenise P; Terracina S; Prossomariti G; Boscherini B
Eur J Endocrinol; 1995 Jan; 132(1):42-6. PubMed ID: 7850009
[TBL] [Abstract][Full Text] [Related]
22. Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment.
Borderie D; Cherruau B; Dougados M; Ekindjian OG; Roux C
Calcif Tissue Int; 1998 Jan; 62(1):21-5. PubMed ID: 9405728
[TBL] [Abstract][Full Text] [Related]
23. Decreased Excretion of Urinary Exosomal Aquaporin-2 in a Puromycin Aminonucleoside-Induced Nephrotic Syndrome Model.
Abdeen A; Sonoda H; Kaito A; Oshikawa-Hori S; Fujimoto N; Ikeda M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560242
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
25. Serum and urinary ceruloplasmin in experimental nephrotic syndrome.
Mainero A; Cruz C; Pedraza-Chaverrí J
Clin Invest Med; 1992 Aug; 15(4):295-300. PubMed ID: 1516286
[TBL] [Abstract][Full Text] [Related]
26. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
27. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
29. Effects of low phosphate intake on bone and mineral metabolism in rats: evaluation by biochemical markers and pyridinium cross-link formation in bone.
Hoshino H; Kushida K; Takahashi M; Koyama S; Yamauchi H; Inoue T
Ann Nutr Metab; 1998; 42(2):110-8. PubMed ID: 9625281
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus.
Sosa M; Dominguez M; Navarro MC; Segarra MC; Hernández D; de Pablos P; Betancor P
J Diabetes Complications; 1996; 10(4):201-5. PubMed ID: 8835919
[TBL] [Abstract][Full Text] [Related]
31. High density lipoproteinuria in nephrotic syndrome.
de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
[TBL] [Abstract][Full Text] [Related]
32. Low bone mineral mass is associated with decreased bone formation and diet in girls with Rett syndrome.
Motil KJ; Barrish JO; Neul JL; Glaze DG
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):386-92. PubMed ID: 25144778
[TBL] [Abstract][Full Text] [Related]
33. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
34. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
Yu Z; Schumacher M; Frey BM; Frey FJ; Vogt B
Nephron Physiol; 2005; 101(3):p51-62. PubMed ID: 16020936
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral content and bone metabolism in young adults with severe periodontitis.
von Wowern N; Westergaard J; Kollerup G
J Clin Periodontol; 2001 Jun; 28(6):583-8. PubMed ID: 11350527
[TBL] [Abstract][Full Text] [Related]
36. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
[TBL] [Abstract][Full Text] [Related]
37. Electrophoretic analysis of serum and urinary proteins in rats with aminonucleoside-induced nephrotic syndrome.
Pedraza-Chaverrí J; Calderón P; Cruz C; Peña JC
Ren Fail; 1993; 15(2):149-55. PubMed ID: 8469781
[TBL] [Abstract][Full Text] [Related]
38. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Olmos JM; Pérez-Castrillón JL; García MT; Garrido JC; Amado JA; González-Macías J
Bone Miner; 1994 Jul; 26(1):1-8. PubMed ID: 7950501
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection.
Haderslev KV; Jeppesen PB; Sorensen HA; Mortensen PB; Staun M
Gut; 2003 May; 52(5):653-8. PubMed ID: 12692048
[TBL] [Abstract][Full Text] [Related]
40. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction.
Hyldstrup L; Andersen T; McNair P; Breum L; Transbøl I
Acta Endocrinol (Copenh); 1993 Nov; 129(5):393-8. PubMed ID: 8279220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
